NexPoint Life Sciences III DST

Amendment
CIK: 0002008210·Other Real Estate·DELAWARE·Filed: Jan 13, 2026
Total Offering

$30,661,253

Amount Sold

$25,178,789

Investors

81

First Sale

Jan 25, 2024

Offering Details

Type
Equity, Pooled Investment Fund
Exemptions
Rule 506(c), Section 3(c), Section 3(c)(1), Section 3(c)(5)

Related Persons

NameRole
NexPoint Real Estate Advisors IV, L.P.
Executive Officer
Brian Mitts
Executive Officer
Matt McGraner
Executive Officer
NREA LS III Manager, LLC
Executive Officer
NREA LS III Contributor, LLC
Executive Officer

Company

NexPoint Life Sciences III DST

300 CRESCENT COURT

DALLAS, TX, 75201

(833) 697-6246

SEC Filing

0002008210-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free